Skip to main content

Harnessing single-cell transcriptomics for the determination of sexual dimorphism during Plasmodium falciparum gametocytogenesis

NIAID - National Institute of Allergy and Infectious Diseases

open
OpenLast verified: 2026-06-18

About This Grant

PROJECT SUMMARY/ABSTRACT Unlike higher eukaryotes, unicellular organisms like the malaria parasite Plasmodium falciparum rely on the precise regulation of molecular events that stabilize the development of one sex lineage and/or repress the alternative fate. The development of P. falciparum is closely tied to its complex life cycle where sexual differentiation within a subpopulation of host red blood cells is critical for transmission to the mosquito vector. This sexual lifecycle stage, known as gametocytogenesis is a lengthy process, taking approximately 12 days to transition from immature sexual stages (stage I) to mature, differentiated male and female stages (stage V) that can be taken up by the female anopheles mosquito. Despite extensive research efforts, the molecular mechanisms governing sexual development and dimorphism in P. falciparum remain poorly understood. Recent studies have begun to shed light on sexual development using single-cell RNA sequencing (scRNA-Seq) and have defined a Malaria Cell Atlas,. These studies suggest that sexual fate in malaria parasites is likely determined downstream of commitment, following a branch point during gametocytogenesis. However, significant knowledge gaps persist, particularly regarding the timing and regulation of sex dimorphism. To address these gaps, we propose a comprehensive study leveraging scRNA-Seq to uncover the molecular mechanisms of cell fate determination using a combination of parasite genotypes from different geographical locations and unique genetic mutants in key regulators of gametocytogenesis. Our approach is structured around two specific aims. The first aim will determine the temporal, single-cell transcriptional landscape of gametocytogenesis using the 10x Genomics chromium platform with short-read (Illumina) sequencing using P. falciparum strains from varying genetic backgrounds of Africa, South America, and Southeast Asia origin. We will also refine the classification of gametocyte clusters associated with distinct stages (I-V) of gametocytogenesis and better delineate the earliest lineage bifurcations along the sexual trajectory. To accomplish this, we will measure and compare temporal, scRNA-Seq data from genetically modified strains with defects in known regulators of sexual-stage development. The second aim will capture the evolutionary dynamics of sex-specific transcript isoform diversity. To assess the downstream impact of isoform regulators on gametocyte development, differentiation efficiency, morphology, and reproductive success, we will couple long-read (PacBio) sequencing to better elucidate masked transcriptional modules and differential exon usage during gametocytogenesis. Additionally, we will validate the role of candidate hub isoform regulator(s) using genetic manipulation techniques such as DiCre-inducible conditional knockout (cKO). The outcomes of this proposal include identifying key regulators of sexual dimorphism and lineage-specific transcript isoforms used by malaria parasites to prepare for mosquito transmission.

Grant Summary

Harnessing single-cell transcriptomics for the determination of sexual dimorphism during Plasmodium falciparum gametocytogenesis is a NIAID - National Institute of Allergy and Infectious Diseases grant providing up to $197K for university, nonprofit, healthcare org. Applications are due 2028-04-30 (open). Check eligibility and apply with FindGrants.

Focus Areas

health research

Eligibility

universitynonprofithealthcare org

How to Apply

Funding Range

Up to $197K

Deadline

2028-04-30

Complexity
Medium
  1. 1Confirm your organization is eligible for Harnessing single-cell transcriptomics for the determination of sexual dimorphism during Plasmodium falciparum gametocytogenesis from NIAID - National Institute of Allergy and Infectious Diseases, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIAID - National Institute of Allergy and Infectious Diseases before the deadline.
This record is a past award, contract, or funder profile — useful for research, but not an open grant application. Check the original source for current opportunities from this funder.

Don't want to draft it yourself?

We'll draft the complete application against NIAID - National Institute of Allergy and Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

Harnessing single-cell transcriptomics for the determination of sexual dimorphism during Plasmodium falciparum gametocytogenesis: Frequently Asked Questions

Who is eligible for the Harnessing single-cell transcriptomics for the determination of sexual dimorphism during Plasmodium falciparum gametocytogenesis?

Harnessing single-cell transcriptomics for the determination of sexual dimorphism during Plasmodium falciparum gametocytogenesis is offered by NIAID - National Institute of Allergy and Infectious Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the Harnessing single-cell transcriptomics for the determination of sexual dimorphism during Plasmodium falciparum gametocytogenesis provide?

Harnessing single-cell transcriptomics for the determination of sexual dimorphism during Plasmodium falciparum gametocytogenesis provides up to $197K per award from NIAID - National Institute of Allergy and Infectious Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the Harnessing single-cell transcriptomics for the determination of sexual dimorphism during Plasmodium falciparum gametocytogenesis deadline?

Applications for Harnessing single-cell transcriptomics for the determination of sexual dimorphism during Plasmodium falciparum gametocytogenesis are due 2028-04-30 (open). Because deadlines can change, verify the date with the funder, NIAID - National Institute of Allergy and Infectious Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.

How do you apply for the Harnessing single-cell transcriptomics for the determination of sexual dimorphism during Plasmodium falciparum gametocytogenesis?

To apply for Harnessing single-cell transcriptomics for the determination of sexual dimorphism during Plasmodium falciparum gametocytogenesis, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIAID - National Institute of Allergy and Infectious Diseases.

Browse More Grants